美国 · SEC FORM 4
Oscar Health, Inc.
OSCR · NYSE · CIK 0001568651 · Healthcare · Healthcare Plans
内部人信号
当前没有活跃买入信号
0 qualifying P purchase groups
当前 180 天评分窗口
65 同一窗口内观察到的 Form 4 交易行
44 sales · 21 期权、代扣税、授予、赠与或其他交易行
最近一次合资格买入2026-04-06 · Bertolini Mark T · $11.9M
为什么没有活跃信号？
买入活动无
近期买入无
近期卖出High
买入信号状态未激活
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
AprMayJunJulAugSepOct
Schlosser MarioDirector
▼○▼○▼○▼○▼▼
Blackley Richard ScottChief Financial Officer
▼▼▼▼▼
Bertolini Mark TChief Executive Officer
▼▼▼▼
WITTMAN VANESSA AMESDirector
○▼
McAnaney AdamChief Legal Officer
▼▼
Liang JanetPresident, Oscar Insurance
▼▼
● 买入▼ 卖出○ 其他
Showing the six most active owners; 7 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
暂无已记录的活跃信号快照
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-04-06 · Bertolini Mark T.
近期 Form 4 活动
1买入
61卖出
36其他 Form 4 交易行
44SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出44 sale line(s) · 仅供背景
其他21 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 16,451,694
- 上期报告
- 17,770,151
- 日均成交量
- 6,135,580
- 回补天数
- 2.7
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-04-06 | Bertolini Mark T | 买入 (P) | Class A Common Stock | 1,000,000 | USD 11.92 | USD 11,920,000 | SEC 申报 ↗ |
| 2024-11-21 | Kushner Joshua | 买入 (P) | Class A Common Stock | 100,000 | USD 16.86 | USD 1,686,000 | SEC 申报 ↗ |
| 2024-11-21 | Claremount VII Associates, L.P.; Thrive Capital Partners VII Growth, L.P.; Thrive Partners VII GP, LLC; Thrive Partners VII Growth GP, LLC | 买入 (P) | Class A Common Stock | 100,000 | USD 16.86 | USD 1,686,000 | SEC 申报 ↗ |
| 2024-11-20 | Kushner Joshua | 买入 (P) | Class A Common Stock | 88,395 | USD 16.97 | USD 1,500,063 | SEC 申报 ↗ |
| 2024-11-20 | Claremount VII Associates, L.P.; Thrive Capital Partners VII Growth, L.P.; Thrive Partners VII GP, LLC; Thrive Partners VII Growth GP, LLC | 买入 (P) | Class A Common Stock | 88,395 | USD 16.97 | USD 1,500,063 | SEC 申报 ↗ |
| 2024-11-14 | Kushner Joshua | 买入 (P) | Class A Common Stock | 344,522 | USD 15.80 | USD 5,444,873 | SEC 申报 ↗ |
| 2024-11-14 | Claremount VII Associates, L.P.; Thrive Capital Partners VII Growth, L.P.; Thrive Partners VII GP, LLC; Thrive Partners VII Growth GP, LLC | 买入 (P) | Class A Common Stock | 344,522 | USD 15.80 | USD 5,444,873 | SEC 申报 ↗ |
| 2024-11-13 | Kushner Joshua | 买入 (P) | Class A Common Stock | 358,619 | USD 13.74 | USD 4,927,425 | SEC 申报 ↗ |
| 2024-11-13 | Claremount VII Associates, L.P.; Thrive Capital Partners VII Growth, L.P.; Thrive Partners VII GP, LLC; Thrive Partners VII Growth GP, LLC | 买入 (P) | Class A Common Stock | 358,619 | USD 13.74 | USD 4,927,425 | SEC 申报 ↗ |
| 2024-11-12 | Kushner Joshua | 买入 (P) | Class A Common Stock | 420,819 | USD 13.68 | USD 5,756,804 | SEC 申报 ↗ |
| 2024-11-12 | Claremount VII Associates, L.P.; Thrive Capital Partners VII Growth, L.P.; Thrive Partners VII GP, LLC; Thrive Partners VII Growth GP, LLC | 买入 (P) | Class A Common Stock | 420,819 | USD 13.68 | USD 5,756,804 | SEC 申报 ↗ |
| 2024-11-11 | Kushner Joshua | 买入 (P) | Class A Common Stock | 276,040 | USD 13.58 | USD 3,748,623 | SEC 申报 ↗ |
| 2024-11-11 | Claremount VII Associates, L.P.; Thrive Capital Partners VII Growth, L.P.; Thrive Partners VII GP, LLC; Thrive Partners VII Growth GP, LLC | 买入 (P) | Class A Common Stock | 276,040 | USD 13.58 | USD 3,748,623 | SEC 申报 ↗ |
| 2021-09-16 | Schlosser Mario | 买入 (P) | Class A Common Stock | 57,300 | USD 17.53 | USD 1,004,469 | SEC 申报 ↗ |
| 2021-09-15 | Kushner Joshua | 买入 (P) | Class A Common Stock | 323,725 | USD 17.86 | USD 5,781,728 | SEC 申报 ↗ |
Form 4 申报证据
98 transaction lines in the latest 365-day window; 527 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-18 | WITTMAN VANESSA AMES | 卖出 (S) | Class A Common Stock | 25,000 | USD 32.24 | USD 806,000 | SEC 申报 ↗ |
| 2026-09-18 | Kushner Joshua | J (J) | Class A Common Stock | 12,687,234 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-18 | Claremount TW, L.P.; Claremount VII Associates, L.P.; Thrive Capital Partners II, L.P.; Thrive Capital Partners III, L.P.; Thrive Capital Partners VII Growth, L.P.; Thrive Partners II GP, LLC; Thrive Partners III GP, LLC; Thrive Partners VII GP, LLC; Thrive Partners VII Growth GP, LLC | J (J) | Class A Common Stock | 12,687,234 | USD 0.00 | USD 0 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-18 | WITTMAN VANESSA AMES | 卖出 (S) | Class A Common Stock | 25,000 | USD 32.24 | USD 806,000 | SEC 申报 ↗ |
| 2026-09-18 | Kushner Joshua | J (J) | Class A Common Stock | 12,687,234 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-18 | Claremount TW, L.P.; Claremount VII Associates, L.P.; Thrive Capital Partners II, L.P.; Thrive Capital Partners III, L.P.; Thrive Capital Partners VII Growth, L.P.; Thrive Partners II GP, LLC; Thrive Partners III GP, LLC; Thrive Partners VII GP, LLC; Thrive Partners VII Growth GP, LLC | J (J) | Class A Common Stock | 12,687,234 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-03 | Schlosser Mario | 卖出 (S) | Class A Common Stock | 31,422 | USD 31.45 | USD 988,222 | SEC 申报 ↗ |
| 2026-09-03 | McAnaney Adam | 卖出 (S) | Class A Common Stock | 9,092 | USD 31.45 | USD 285,943 | SEC 申报 ↗ |
| 2026-09-03 | Liang Janet | 卖出 (S) | Class A Common Stock | 10,360 | USD 31.45 | USD 325,822 | SEC 申报 ↗ |
| 2026-09-03 | Blackley Richard Scott | 卖出 (S) | Class A Common Stock | 28,869 | USD 31.45 | USD 907,930 | SEC 申报 ↗ |
| 2026-09-03 | Baltrus Victoria | 卖出 (S) | Class A Common Stock | 958 | USD 31.45 | USD 30,129 | SEC 申报 ↗ |
| 2026-08-28 | Schlosser Mario | 卖出 (S) | Class A Common Stock | 150,000 | USD 30.79 | USD 4,618,500 | SEC 申报 ↗ |
| 2026-08-28 | Schlosser Mario | C (C) | Class A Common Stock | 150,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-08-27 | Schlosser Mario | 卖出 (S) | Class A Common Stock | 600,000 | USD 30.34 | USD 18,204,000 | SEC 申报 ↗ |
| 2026-08-27 | Schlosser Mario | C (C) | Class A Common Stock | 600,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-08-18 | Blackley Richard Scott | 卖出 (S) | Class A Common Stock | 18,750 | USD 31.74 | USD 595,125 | SEC 申报 ↗ |
| 2026-07-01 | Schlosser Mario | 卖出 (S) | Class A Common Stock | 47,500 | USD 31.24 | USD 1,484,014 | SEC 申报 ↗ |
| 2026-07-01 | Schlosser Mario | C (C) | Class A Common Stock | 47,500 | USD — | USD — | SEC 申报 ↗ |
| 2026-06-30 | Bertolini Mark T | 卖出 (S) | Class A Common Stock | 624,244 | USD 28.48 | USD 17,781,383 | SEC 申报 ↗ |
| 2026-06-29 | Bertolini Mark T | 卖出 (S) | Class A Common Stock | 614,752 | USD 29.26 | USD 17,985,938 | SEC 申报 ↗ |
| 2026-06-26 | Bertolini Mark T | 卖出 (S) | Class A Common Stock | 591,168 | USD 29.28 | USD 17,310,761 | SEC 申报 ↗ |
| 2026-06-25 | Bertolini Mark T | 卖出 (S) | Class A Common Stock | 615,142 | USD 28.61 | USD 17,601,317 | SEC 申报 ↗ |
| 2026-06-23 | Schlosser Mario | 卖出 (S) | Class A Common Stock | 1,027,398 | USD 29.38 | USD 30,180,344 | SEC 申报 ↗ |
| 2026-06-23 | Schlosser Mario | C (C) | Class A Common Stock | 977,500 | USD — | USD — | SEC 申报 ↗ |
| 2026-06-04 | WITTMAN VANESSA AMES | 奖励／授予 (A) | Class A Common Stock | 8,475 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | Sankaran Sid | 奖励／授予 (A) | Class A Common Stock | 8,475 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | Plouffe David | 奖励／授予 (A) | Class A Common Stock | 8,475 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | Lang Laura W | 奖励／授予 (A) | Class A Common Stock | 8,475 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | Gassen William | 奖励／授予 (A) | Class A Common Stock | 8,475 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-02 | Schlosser Mario | 卖出 (S) | Class A Common Stock | 34,120 | USD 21.94 | USD 748,633 | SEC 申报 ↗ |
| 2026-06-02 | McAnaney Adam | 卖出 (S) | Class A Common Stock | 9,859 | USD 21.94 | USD 216,318 | SEC 申报 ↗ |
| 2026-06-02 | Liang Janet | 卖出 (S) | Class A Common Stock | 12,475 | USD 21.94 | USD 273,716 | SEC 申报 ↗ |
| 2026-06-02 | Blackley Richard Scott | 卖出 (S) | Class A Common Stock | 31,683 | USD 21.94 | USD 695,162 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | OSCR |
| CIK | 0001568651 |
| 行业 | Healthcare |
| 细分行业 | Healthcare Plans Yahoo Finance |
| SEC SIC | 6324 Hospital & Medical Service Plans |
| 交易所 | NYSE |
数据覆盖
| 本地 Form 4 历史 | 527 transaction lines from 2021-03-05 to 2026-09-18 66 P purchase lines · 196 S sale lines · 265 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.